{
  "symbol": "ARWR",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["Biotechnology sector", "RNAi therapeutic developments", "Clinical trial phases"],
    "riskScore": 7,
    "reason": "Arrowhead Pharmaceuticals operates in the biotechnology sector, which is prone to speculation due to its involvement in RNAi therapeutics and various clinical trial phases."
  }
}